4133.TW Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 01:30):

Stats
Today's Volume	286 970
Average Volume	188 866
Market Cap	1.82B
EPS	TWD0.170 ( 2023-09-30 )
Last Dividend	TWD0 ( N/A )
Next Dividend	TWD0 ( N/A )
P/E	41.74
ATR14	TWD0.0490 (0.16%)

Volume Correlation

Long: -0.14 (neutral)

Short: -0.69 (moderate negative)

Signal:(48.853) Neutral

Abnova (Taiwan) Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Abnova (Taiwan) Correlation - Currency/Commodity

-0.60
( weak negative )

0.00
( neutral )

0.72
( moderate )

0.56
( weak )

0.21
( neutral )

Abnova (Taiwan) Financials

Annual	2023
Revenue:	TWD382.05M
Gross Profit:	TWD173.92M (45.52 %)
EPS:	TWD0.720

Q4	2023
Revenue:	TWD93.98M
Gross Profit:	TWD45.18M (48.08 %)
EPS:	TWD0.180

Q3	2023
Revenue:	TWD93.90M
Gross Profit:	TWD40.61M (43.25 %)
EPS:	TWD0.170

Q2	2023
Revenue:	TWD98.76M
Gross Profit:	TWD43.20M (43.75 %)
EPS:	TWD0.200

Financial Reports:

No articles found.

Abnova (Taiwan)

Abnova (Taiwan) Corporation manufactures and sells various recombinant proteins and antibodies. The company's products portfolio includes SARS-CoV/CoV-2, DNA and RNA, proteins/peptides, DNAxPab, beads/dyes, lysates/slides, antibody pairs/kits, antibody and tissue arrays, in situ hybridization products, systems and automations, GMP and analyte specific reagents, and in vitro diagnostics. It also provides MaxPab, monoclonal, polyclonal, recombinant, conjugate, secondary/tag, IHC/pathology, and circulating rare cell antibodies. In addition, the company offers integrated solutions and services, including gene synthesis and cytogenetics; peptide services, protein expression, and conjugations; antibody production; and assay development services. Abnova (Taiwan) Corporation is headquartered in Taipei, Taiwan.